|
WO2018127585A1
|
|
Monospecific regulatory t cell population with cytotoxicity for b cells
|
|
EP3346001A1
|
|
Monospecific regulatory t cell population with cytotoxicity for b cells
|
|
EP2982746A1
|
|
Regulatory T cells with therapeutic potential
|
|
EP2604245A1
|
|
Device for medical purposes
|
|
CA2831018A1
|
|
Method for using regulatory t cells in therapy
|
|
EP2439534A1
|
|
Method for assessing the efficacy of a TR1 cell therapy in asubject
|
|
EP2412802A1
|
|
IL-13 producing TR1-like cells and use thereof
|
|
EP2378287A1
|
|
New method for isolating Tr1 cells
|
|
EP2221364A1
|
|
Compositions for treating an allergic or asthmatic condition
|
|
KR20100076031A
|
|
Tr1 cells, mesenchymal stem cells and uses thereof
|
|
EP2113254A1
|
|
Compositions for treating an inflammatory auto-immune condition
|
|
EP2113560A1
|
|
Compositions for treating an arthritic condition
|
|
EP2062970A1
|
|
Compositions for treating an intestinal inflammatory condition
|
|
US2009104142A1
|
|
Compositions for treating multiple sclerosis
|
|
EP2050814A1
|
|
Compositions for treating multiple sclerosis
|
|
EP1712615A1
|
|
In vitro production of a cell population using feeder cells
|
|
FR2856700A1
|
|
METHOD FOR IDENTIFYING TR1 REGULATORY LYMPHOCYTES BY THE PRESENCE AND OVEREXPRESSION OF SPECIFIC MOLECULES AND APPLICATIONS THEREOF
|
|
FR2852967A1
|
|
Process for obtaining dendritic cells and t cells
|
